Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jacqueline Kintz"'
Autor:
Johann Foloppe, Juliette Kempf, Nicolas Futin, Jacqueline Kintz, Pascale Cordier, Christelle Pichon, Annie Findeli, Fabien Vorburger, Eric Quemeneur, Philippe Erbs
Publikováno v:
Molecular Therapy: Oncolytics, Vol 14, Iss , Pp 1-14 (2019)
Oncolytic vaccinia viruses are currently in clinical development. However, the safety and the tumor selectivity of these oncolytic viruses must be improved. We previously constructed a first-generation oncolytic vaccinia virus by expressing the suici
Externí odkaz:
https://doaj.org/article/35a655137d434081af3a44ab9dfcb826
Autor:
Laetitia Fend, Nathalie Accart, Jacqueline Kintz, Sandrine Cochin, Carine Reymann, Fabrice Le Pogam, Jean-Baptiste Marchand, Thierry Menguy, Philippe Slos, Ronald Rooke, Sylvie Fournel, Jean-Yves Bonnefoy, Xavier Préville, Hélène Haegel
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73310 (2013)
Tumor progression is promoted by Tumor-Associated Macrophages (TAMs) and metastasis-induced bone destruction by osteoclasts. Both myeloid cell types depend on the CD115-CSF-1 pathway for their differentiation and function. We used 3 different mouse c
Externí odkaz:
https://doaj.org/article/d3a85d0c24d74063b2c5b4d780ad6d10
Autor:
Xavier Préville, Sylvie Fournel, Sandrine Cochin, Karola Rittner, Emmanuelle Schaedler, Murielle Gantzer, Jacqueline Kintz, Tanja Gatard-Scheikl, Laetitia Fend
Supplementary Figure 3. Percentages of splenic and tumor infiltrating T lymphocytes expressing CCR1, CCR2, CCR3 or CCR5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bfc98f7cdd80968eae7f3f5d9375b3
https://doi.org/10.1158/2326-6066.22535912
https://doi.org/10.1158/2326-6066.22535912
Autor:
Xavier Préville, Sylvie Fournel, Sandrine Cochin, Karola Rittner, Emmanuelle Schaedler, Murielle Gantzer, Jacqueline Kintz, Tanja Gatard-Scheikl, Laetitia Fend
Supplementary Figure Legend from Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48cb3b18caef0bf3fd9022337f562b5b
https://doi.org/10.1158/2326-6066.22535909.v1
https://doi.org/10.1158/2326-6066.22535909.v1
Autor:
Xavier Préville, Sylvie Fournel, Sandrine Cochin, Karola Rittner, Emmanuelle Schaedler, Murielle Gantzer, Jacqueline Kintz, Tanja Gatard-Scheikl, Laetitia Fend
Supplementary Figure 2. Infiltration of contralateral kidneys from tumor-bearing mice by CD45 positive cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d46675b142bc10b39e2fc842a43dfa
https://doi.org/10.1158/2326-6066.22535915.v1
https://doi.org/10.1158/2326-6066.22535915.v1
Autor:
Xavier Préville, Sylvie Fournel, Sandrine Cochin, Karola Rittner, Emmanuelle Schaedler, Murielle Gantzer, Jacqueline Kintz, Tanja Gatard-Scheikl, Laetitia Fend
Effector T-cell access to tumor tissue is a limiting step for clinical efficacy of antigen-specific T cell–based immunotherapies. Ectopic mouse tumor models, in which a subcutaneously (s.c.) implanted tumor is treated with s.c. or intramuscular the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f7663080d708fe571884c0619a7d3dc
https://doi.org/10.1158/2326-6066.c.6547982.v1
https://doi.org/10.1158/2326-6066.c.6547982.v1
Autor:
Xavier Préville, Sylvie Fournel, Sandrine Cochin, Karola Rittner, Emmanuelle Schaedler, Murielle Gantzer, Jacqueline Kintz, Tanja Gatard-Scheikl, Laetitia Fend
Supplementary Table 1. Inflammatory gene expression analysis in tumor bearing kidney.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0448e3b908fec73949ed4d707f789169
https://doi.org/10.1158/2326-6066.22535906
https://doi.org/10.1158/2326-6066.22535906
Autor:
Jacqueline Kintz, Nicolas Futin, Juliette Kempf, Christelle Pichon, Johann Foloppe, Annie Findeli, Philippe Erbs, Pascale Cordier, Fabien Vorburger, Eric Quemeneur
Publikováno v:
Molecular Therapy: Oncolytics, Vol 14, Iss, Pp 1-14 (2019)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Oncolytic vaccinia viruses are currently in clinical development. However, the safety and the tumor selectivity of these oncolytic viruses must be improved. We previously constructed a first-generation oncolytic vaccinia virus by expressing the suici
Autor:
Laetitia Fend, Xavier Préville, Sandrine Cochin, Murielle Gantzer, Emmanuelle Schaedler, Karola Rittner, Jacqueline Kintz, Sylvie Fournel, Tanja Gatard-Scheikl
Publikováno v:
Cancer Immunology Research. 2:1163-1174
Effector T-cell access to tumor tissue is a limiting step for clinical efficacy of antigen-specific T cell–based immunotherapies. Ectopic mouse tumor models, in which a subcutaneously (s.c.) implanted tumor is treated with s.c. or intramuscular the
Autor:
Annie Findeli, Pascale Cordier, Jacqueline Kintz, Johann Foloppe, Yasmin Schlesinger, Futin N, Philippe Erbs, Chantal Hoffmann, Jean-Marc Balloul, Caroline Tosch
Publikováno v:
Gene Therapy. 15:1361-1371
We have generated a thymidine kinase gene-deleted vaccinia virus (VV) (Copenhagen strain) that expressed the fusion suicide gene FCU1 derived from the yeast cytosine deaminase and uracil phosphoribosyltransferase genes. Intratumoral inoculation of th